Kosnopfel C, Sinnberg T, Sauer B, et al. MAPK inhibitor resistant melanoma cells can be effectively targeted by inhibition of the p90 ribosomal S6 kinase. SMR 2017, abstract P01-9.
Lenvatinib plus pembrolizumab bij gevorderd endometriumcarcinoom
mei 2019 | Gynaecologische oncologie